Brief: Clovis Oncology Retires Remaining 2021 Notes And Raises Additional Capital Through Its ATM Equity Offering Program
20/09/2021 13:11
Sept 20 (Reuters) - Clovis Oncology Inc CLVS.O :
* CLOVIS ONCOLOGY RETIRES REMAINING 2021 NOTES AND RAISES
ADDITIONAL CAPITAL THROUGH ITS ATM EQUITY OFFERING PROGRAM
* CLOVIS ONCOLOGY INC - THREE PHASE 3 TOPLINE RUBRACA DATA
READOUTS EXPECTED IN 2022
* CLOVIS ONCOLOGY INC - INITIAL DATA FROM LUMIERE STUDY OF
TARGETED RADIOTHERAPY CANDIDATE FAP-2286 ALSO EXPECTED IN 2022
Source text for Eikon: ID:nBw1D479Na
Further company coverage: CLVS.O
Recent news on Clovis Oncology
See all newsBrief: Clovis Oncology Inc - On April 5, 2023, Entered Into Asset Purchase Agreement With Pharma& To Sell Product Business For Upfront Payment Of $70 Million
Brief: Clovis Oncology Enters Into Financing Agreement
Brief: Clovis Oncology Inc Received Written Notice From Nasdaq That Company's Common Stock Will Be Delisted From Nasdaq
U.S. STOCKS ON THE MOVE-Nike, Faraday Future, PBF Energy
U.S. STOCKS ON THE MOVE-Natural gas, Box Inc, Weber